CASSUNDRA SHUKLA: Open Payments
NPI 1083033153 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114 in 6 payments from 4 companies in 2025. Trend: 2023 $842 · 2024 $1,434 · 2025 $114
Food & beverage: $114
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $15 |
Products named: VENCLEXTA, CALQUENCE, Vyloy, Vanflyta.
Industry payments across CA — which companies pay providers there.
